CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The MAGICBULLET project focuses on developing peptide-drug conjugates that target tumor cells for cancer therapy. By utilizing tumor-specific peptides and potent cytotoxic drugs, the project aims to enhance the effectiveness of cancer treatments while addressing challenges in drug delivery and manufacturing.
Many tumor cells are characterized by the overexpression of certain antigens.
Molecules that specifically recognize these structures are suitable as homing devices in tumor therapy.
Conjugates of anticancer drugs with such a delivery vector targeting tumors would be a “magic bullet” according to the Nobel laureate Paul Ehrlich.
Three antibody-drug conjugates (ADC) have already been approved for anticancer therapy.
However, ADC have e.g. limitations with respect to tumor penetration, high manufac…
UNIVERSITAET BIELEFELD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Italy, Varese
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Hungary, Budapest
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Finland, HELSINGIN YLIOPISTO
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Milano
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
